Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Portfolio Pulse from Benzinga Neuro
Sen. Bernie Sanders criticized the high cost of healthcare in the U.S., highlighting the financial burden on patients. He specifically mentioned the high prices of drugs from Novo Nordisk, Eisai Co Ltd, Biogen Inc, Johnson & Johnson, Merck, and Bristol-Myers Squibb.
July 16, 2024 | 1:36 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biogen Inc was criticized by Bernie Sanders for the high price of its Alzheimer's treatment Leqembi.
Negative attention from Sanders could lead to regulatory actions or public pressure, potentially affecting Biogen's stock negatively in the short term.
CONFIDENCE 85
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Bristol-Myers Squibb was criticized by Bernie Sanders for the high prices of its lifesaving drugs.
Sanders' criticism could lead to increased scrutiny and public backlash, potentially impacting Bristol-Myers Squibb's stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Johnson & Johnson was criticized by Bernie Sanders for the high prices of its lifesaving drugs.
Sanders' criticism could lead to increased scrutiny and public backlash, potentially impacting Johnson & Johnson's stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Merck was criticized by Bernie Sanders for the high prices of its lifesaving drugs.
Sanders' criticism could lead to increased scrutiny and public backlash, potentially impacting Merck's stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 50
RELEVANCE 60
NEGATIVE IMPACT
Novo Nordisk was criticized by Bernie Sanders for the high prices of its diabetes drug Ozempic.
Sanders' criticism could lead to increased regulatory scrutiny and public backlash, potentially impacting Novo Nordisk's stock negatively in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80